Urinary Tract Infections: OM-89 Treatment Study

We are investigating whether OM-89 can help reduce antibiotic use in patients with a neurological bladder due to spinal cord injury. This study will compare its effects to a placebo over two years.

1-2 years 11-15 visits Confirmation phase (III)Post-Trial Drug Access Partially Remote Standard Medicines OralInfectious DiseasesUrology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Uro-Vaxom

Uro-Vaxom is a medicine used to help prevent recurrent urinary tract infections.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

E. Coli Extract (Lysate)

E. coli extract (lysate) is a substance that helps stimulate the immune system to reduce recurrent urinary tract infections.

E.Coli Extract

E. coli extract is a substance that stimulates the immune system to help prevent recurrent urinary tract infections.

E.Coli Polysaccharide

E. coli polysaccharide is a substance used in vaccines to stimulate immune protection against infections caused by E. coli bacteria.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Centre Hospitalier Regional Universitaire De Tours

Urologie

La Riche, France

Centre Hospitalier Universitaire De Lille

Urologie

Loos, France

Centre Hospitalier Universitaire De Nimes

Maladies infectieuses et tropicales

Milhaud, France

Sponsor: Centre Hospitalier Universitaire De Dijon

Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.